年轻、女性及出现全身不良反应与接种两剂BNT162b2 mRNA SARS-CoV-2疫苗后高抗体滴度相关:646名日本医护人员和大学教职工的观察性研究
这项前瞻性观察性研究纳入646名日本医护人员和大学教职工,在接种两剂BNT162b2疫苗前后采集血清,分析抗体滴度与性别、年龄及不良反应的关系。结果显示所有受试者均转为血清阳性,抗体滴度个体差异大,女性、年轻(≤45岁)及出现不良反应者抗体滴度更高;多变量分析表明年轻、女性及第二剂后不良反应独立相关于更高抗体滴度。作者认为全身不良反应(如发热和疲劳)与更高的抗体反应相关,提示获得体液免疫。
要点
- 接种两剂BNT162b2后所有646名受试者均血清阳性,抗体滴度中位数13478.0AU/mL,范围260.9-57,399.7AU/mL。
- 女性平均抗体滴度高于男性,年轻(≤45岁)者高于年长(>45岁)者。
- 出现不良反应者抗体滴度高于无不良反应者;多变量分析显示年轻、女性及第二剂后不良反应独立相关于更高抗体滴度。
核心结论
- 在 mostly healthy 日本受试者中,接种两剂BNT162b2后观察到良好的抗体反应,尤其在女性和年轻受试者中。
- 作者认为全身不良反应(即发热和全身疲劳)与更高的抗体反应相关,提示获得体液免疫,但强调进一步研究至关重要。
研究设计与样本
- 前瞻性观察性研究,纳入673名在日本东京一所医学院及其附属医院工作的日本受试者(UMIN000043340)。
- 在第一剂前和第二剂后三周采集血清样本,测量针对SARS-CoV-2刺突蛋白受体结合域的抗体滴度。
- 通过问卷获取背景特征和不良反应信息,分析抗体滴度与这些因素的关系。
- 排除未完成两剂接种或两次血清采集的受试者后,最终分析646人。
主要发现
- 所有受试者接种后均血清阳性,抗体滴度个体间差异大(260.9-57,399.7AU/mL),中位数13478.0AU/mL。
- 女性平均滴度高于男性,年轻(≤45岁)受试者平均滴度高于年长(>45岁)受试者。
- 出现不良反应的受试者接种后抗体滴度高于无不良反应者。
- 多变量分析显示,年轻、女性及第二剂后不良反应独立相关于第二剂后更高抗体滴度。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: SARS-CoV-2 vaccination has started worldwide, including Japan. Although high rates of vaccine response and adverse reactions of BNT162b2 vaccine have been reported, knowledge about the relationship between sex differences and antibody response is limited. Furthermore, it is uncertain whether adverse reactions are associated with the vaccine response. METHODS: This prospective observational study included 673 Japanese participants working in a medical school and its affiliated hospital in Tokyo, Japan (UMIN000043340). Serum samples were collected before the first dose and three weeks after the second dose of BNT162b2 vaccine, and antibody titers against the receptor-binding domain of the spike protein of SARS-CoV-2 were measured. Answers to questionnaires about background characteristics and adverse reactions were obtained at the time of sample collection, and the relationship between antibody titers was analyzed. RESULTS: After excluding participants who did not complete receiving two doses of vaccination or two series of serum sample collection, 646 participants were analyzed. Although all participants became sero-positive after vaccination, antibody titers were highly variable among individuals (260.9-57,399.7A U/mL), with a median titer of 13478.0AU/mL. Mean titer was higher in females than in males and higher in young (≤45 years old) participants than in aged (>45 years old) participants. Participants who experienced adverse reactions demonstrated a higher antibody titer after vaccination than those without adverse reactions. Multivariable analysis demonstrated that young age, female sex, and adverse reactions after the second dose were independently related to higher antibody titers after the second dose. DISCUSSION: A favorable antibody response was observed after two doses of BNT162b2 vaccination among mostly healthy Japanese participants, especially among female and young participants. Although further investigation is essential, our results imply that the systemic adverse reactions (i.e., fever and general fatigue) are associated with a higher antibody response that indicates the acquisition of humoral immunity.
引用
- Uwamino Y, Kurafuji T, Sato Y, et al. Young age, female sex, and presence of systemic adverse reactions are associated with high post-vaccination antibody titer after two doses of BNT162b2 mRNA SARS-CoV-2 vaccination: An observational study of 646 Japanese healthcare workers and university staff. Vaccine. 2022. PMID: 35033389. doi:10.1016/j.vaccine.2022.01.002
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。